Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
237 Leser
Artikel bewerten:
(1)

CBD Life Sciences Inc.: CBD Life Sciences Inc, Donations 100 units of its Proprietary "CBD+CBG Hand Sanitizer Gel Infused with Vitamin E Oil" to Two Arizona Nursing Homes"

SCOTTSDALE, AZ / ACCESSWIRE / April 23, 2020 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is pleased to announce that they have donated 50 units each of their 100 MG CBD + CBG with Vitamin E Oil Hand Sanitizer Gel. 50 of the units are being delivered today to the Andara Retirement Home/Assisting Living & another 50 units to the Solterra Senior Living in Scottsdale, Arizona.

All of our CBD Oil products are available on our website www.lbcbioscienceinc.com. Follow our social media accounts at www.instagram.com/lbcbioscience, www.twitter.com/lbcbioscience for updating information.

Lisa Nelson, President/CEO of CBD Life Sciences, Inc. commented "We are grateful that LBC Bioscience Inc. is in the situation to help Senior Citizens with our CBD+CBG Hand Sanitizer Gel infused with Vitamin E Oil, during the current COVID-19 Crisis. We hope that our Hand Sanitizers can help Senior Citizens stay safe and healthy during this pandemic."

Lisa Nelson continued "We are selling our CBD + CBG Hand Sanitizer on our website www.lbcbioscienceinc.com and also in our LBC Bioscience Inc. store located at 10855 North 116th Street. Suite 115 in Scottsdale, AZ 85259. Due to the COVID-19 virus, we are offering 20% of your entire order. We look forward to meeting interested readers at our LBC Bioscience Inc. store and welcome their inquiries."

LBC Bioscience Inc. would like to update the public that our CBD Tablets are currently on back order. As soon as we have an update on when the Tablets will be shipped to our facility, we will make an announcement.

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD hemp drops, pain relief creams, anxiety & sleep supplements, CBD edibles including brain booster coffee, weight loss coffee, gummy bears, anti-aging skin line and a full line of CBD infused supplements for your pets. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Contact Information Investor Relations:

Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480)326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

SOURCE: CBD Life Sciences Inc.



View source version on accesswire.com:
https://www.accesswire.com/586572/CBD-Life-Sciences-Inc-Donations-100-units-of-its-Proprietary-CBDCBG-Hand-Sanitizer-Gel-Infused-with-Vitamin-E-Oil-to-Two-Arizona-Nursing-Homes

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.